Dilyara Kaidarova is running for the UICC Board of Directors

Dilyara Kaidarova, Chairman of the board at the Kazakh Institute Of Oncology and Radiology, is a candidate for the 2024-2026 Board of Directors at UICC.

This year, she’s running among other candidates including Eric Bouffet, Tsetsegsaikhan Batmunkh, Stella Aguinaga Bialous, Maira Caleffi, Hana Chaar Choueib, Todd Harper, Christopher Jackson, Matti Aapro, David Kerr, Purna Kurkure, Gilberto Lopes, Kenji Lopez-Cuevas, Asem Mansour, Miriam Mutebi, Omar Nimri, C S Pramesh, Kathleen Schmeler, and Naoto Ueno.

Understanding the healthcare challenges faced by countries with limited funding, Dilyara Kaidarova, as the Director of KazIOR, spearheaded the adoption of the National Cancer Control Plan.

This plan was designed to secure additional funding for existing services and allocate more budget to critical areas such as molecular genetic testing, targeted therapy, and immunotherapy drugs. It also aimed to ensure free imaging for all patients and took measures to provide access to the best cancer care for everyone.

As a cancer care policymaker in the region, Dilyara involved oncologists from Central Asia and the Caucasus, alongside KazIOR, in international collaborations on cancer care, screening, research programs, and tumor boards.

Dilyara has successfully combined extensive clinical responsibilities with research work in oncology, leading to her election to the Lancet Commission, ASCO International Affairs, and the IGCS Council of Asia and Oceania.

Her active involvement in the UICC has provided her with profound experience in promoting comprehensive cancer care, objectives, and principles at both Eurasian and local levels. This culminated in the successful hosting of the World Cancer Leaders’ Summit in Nur-Sultan in 2019.

Previously, as the Medical Director for the Cancer Society of New Zealand, Dilyara instigated the first National Cancer Plan in over 15 years and led advocacy efforts that resulted in the establishment of a national cancer agency.

Her efforts also contributed to the funding of 26 new cancer drugs. She has worked with the International Cancer Benchmarking Project to better understand international variations in outcomes and care. Dilyara brings strong advocacy capabilities to the UICC and has a deep understanding of the challenges related to access to medicines.

Dilyara believes that by working together as a global community, we can be a powerful force for change. Her work with patients, governments, charities, research groups, professional societies, and in advocacy equips her with strong skills to contribute to the UICC.

What Makes Dilyara Kaidarova a Good Candidate for the UICC Board of Directors:

Dilyara Kaidarova graduated from the Kazakh Medical Institute and has 30 years of experience in the field.

Since May 2016, she has served as the Director of the Kazakh Institute of Oncology and Radiology (KazIOR), where she combines clinical, research, and administrative responsibilities.

Dilyara is also a member of the Higher Scientific and Technical Commission under the Government of the Republic of Kazakhstan and has been the Chief Editor of the journal “Oncology and Radiology of Kazakhstan” since 2016.

As a clinician, Dilyara has performed approximately 12,000 surgeries. She is the author of more than 120 scientific publications and serves as a scientific supervisor for PhD students.

Her leadership has expanded the scope of international cooperation for KazIOR in the fields of medical science and training. Since 2009, Dilyara has been a permanent member of ESGO, and since 2010, a member of ASCO.

As a member of the UICC, she played a pivotal role in organizing the World Cancer Leaders’ Summit in Nur-Sultan, Kazakhstan, in 2019.

Interviews with Dilyara Kaidarova

Cancer Control in Kazakhstan: HE Dr. Zainab Shinkafi Bagudu Interviews Dr. Dilyara Kaidarova

In this detailed interview, she highlighted the improvements in cancer treatment accessibility, including free access to targeted therapies, immunotherapies, and chemotherapy for patients in Kazakhstan. She also discussed the ongoing challenges, such as the need for better radiation therapy equipment and addressing pediatric cancer care​.

Awards received by Dilyara Kaidarova:

Dilyara Kaidarova has been recognized for her significant contributions to oncology in Kazakhstan and beyond. Some of the awards and honors she has received include:

1. State Prize of Kazakhstan: She was awarded the State Prize for Science and Technology for her contributions to the field of oncology, particularly for her work on improving cancer treatment and prevention strategies in Kazakhstan.

2. Al-Farabi State Prize: This prestigious award was given to Kaidarova for her groundbreaking work in healthcare and medical research, recognizing her leadership in advancing cancer care and her efforts to improve public health policies in Kazakhstan.

3. Honorary Professor at Various Institutions: Kaidarova has been named an honorary professor at several leading medical universities and institutions in Kazakhstan and other countries. This honor reflects her impact on education and training in the field of oncology.

4. Recognition by International Organizations: Internationally, Kaidarova has been acknowledged by various organizations, including the Union for International Cancer Control (UICC), for her leadership and innovative approaches to cancer control and management.